Combinations of hydrophilic and hydrophobic entities in a biodegradable sustained release implant are shown to modulate each other's rate of release. Formulations of a therapeutically active agent and modulator provide controlled, sustained release for an extended period of time.

 
Web www.patentalert.com

< Methods of inhibiting platelet anti-HLA alloimmune antibody responses with soluble 18 KDa CD40L

< Brain associated inhibitor of tissue-type plasminogen activator

> Compounds and methods for diagnosis and immunotherapy of tuberculosis

> Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same

~ 00264